Abstract:Background: Lung adenocarcinoma (LUAD) is the most common form of lung cancer and is often accompanied by brain metastasis (BM). The heterogeneity of the tumor renders all current conventional treatments less effective. This study aims to dissect tumor cell heterogeneity and identify potential therapeutic targets.Methods: We conducted single-cell RNA-sequencing (scRNA-seq) in 8 patients with treatment-naïve LUAD BM and included scRNA-seq data of 10 primary LUAD samples and their matched adjacent normal tissue from GSE131907 to determine the tumor cell heterogeneity.Results: Our analyses revealed tumor cells derived from brain metastases were more heterogeneous. Tumor cells from BM harbored significantly more copy number variants (CNVs), and cells of magnoid subtype were the critical source of malignant cells both in BM and the primary lung tumor. Pseudo-time trajectory analysis revealed that malignant cells had upregulated genes enriched for cell cycle and cell division. Integrated analysis of tumor cells revealed 2 distinct malignant cell clusters (cluster 4 and cluster 6) and their marker genes. The signatures identified in the single-cell profile had prognostic value in the bulk tumor profiles. Moreover, the signature of cluster 4 had significant prognostic value in predicting patients surviving longer than 3.5 years, while the signature of cluster 6 showed better predictive ability within 1 year. Magnoid-type cells are most likely to develop into the riskiest cell type and potentially promote tumor progression.Conclusions: scRNA profiling that integrates LUAD BM and primary LUAD can provide information on those malignant cells with BM potential, offering additional prognostic information at cellular level, and may serve as a foundational resource for further tumor cell dissection and therapeutic target exploration.

Molecular profiling of human non-small cell lung cancer by single-cell RNA-seq

P59.07 Molecular Profiling of Human Non-Small Cell Lung Cancer by Single-Cell RNA-Seq

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Identification of distinct tumor cell patterns with single-cell RNA sequencing integrating primary lung adenocarcinoma and brain metastasis tumor

Metabolic and senescence characteristics associated with the immune microenvironment in non-small cell lung cancer: insights from single-cell RNA sequencing

Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment

Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer

Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing

Single-cell sequencing technology in tumor research

Prudent Application of Single-Cell RNA Sequencing in Understanding Cellular Features and Functional Phenotypes in Cancer Studies

Additional File 5 of Molecular Profiling of Human Non-Small Cell Lung Cancer by Single-Cell RNA-seq

Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

Single-cell Data Analysis of Malignant Epithelial Cell Heterogeneity in Lung Adenocarcinoma for Patient Classification and Prognosis Prediction.

Characterizing the Metabolic and Immune Landscape of Non-small Cell Lung Cancer Reveals Prognostic Biomarkers Through Omics Data Integration

Single cell RNA sequencing for breast cancer: present and future

Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research

Identification of Multi-landscape and Cell Interactions in the Tumor Microenvironment through High-Coverage Single-Cell Sequencing

Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells

Single-cell RNA Sequencing in Cancer: Applications, Advances, and Emerging Challenges

Advances in single-cell RNA sequencing and its applications in cancer research

The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing